NasdaqGS - Nasdaq Real Time Price USD

Tempus AI, Inc. (TEM)

62.07

+3.41

+(5.81%)

At close: June 6 at 4:00:00 PM EDT

62.18

+0.11

+(0.18%)

After hours: June 6 at 7:59:59 PM EDT

Why Shares of Tempus AI Are Jumping Higher This Week

Tempus AI is developing innovative AI solutions for the treatment of cancer and other diseases. Shares of Tempus AI plummeted after short-seller Spruce Point Capital Management released a critical report on the company. TD Cowen is unalarmed by the information contained in Spruce Point's report.

Motley Fool 2 days ago

TEM
+5.81%
Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape?

TEM's rapid growth and cost discipline are paving the way for a positive adjusted EBITDA in 2025.

Zacks 2 days ago

TEM
+5.81%

GH
Zacks Investment Ideas feature highlights: Tempus AI, SoundHound AI and Innodata

Tempus AI, SoundHound AI, and Innodata post surging growth, offering overlooked exposure to the booming AI trend.

Zacks 2 days ago

TEM
+5.81%

INOD

SOUNW
3 AI Stocks Flying Under the Radar

Outside of the big-time AI players, several companies with notable AI exposure, including Tempus AI, SoundHound AI, and Innodata, have been seemingly overlooked by many.

Zacks 3 days ago

TEM
+5.81%

INOD

SOUNW
Zacks Investment Ideas feature highlights: Nvidia, Alphabet, Constellation Energy and Meta Platform

Nvidia surges amid AI boom as Propense.ai and Tempus AI push into law and healthcare with game-changing tech.

Zacks 3 days ago

TEM
+5.81%

NVDA
Beyond LLMs: How Propense.ai & Tempus AI are Shaking up Legacy Industries

While large language models have been the primary focus of Wall Street, the real asymmetric returns for savvy growth investors will likely come from lesser-known AI segments disrupting legacy industries. Firms like Propense.ai, with its AI-powered B2B cross-selling platform, are gaining traction.

Zacks 4 days ago

TEM
+5.81%
Why Tempus AI, Inc. (TEM) Skyrocketed On Monday

We recently published a list of These 10 Stocks Blew Past Expectations. In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against other top-performing stocks on Monday. Tempus AI extended its winning streak to a third consecutive day on Monday, jumping 15.02 percent to close at $63.47 apiece […]

Insider Monkey 5 days ago

TEM
+5.81%
Why Tempus AI Stock Soared 15% Today

Tempus AI was targeted by a short seller last week. Since then, the company has made several announcements that have helped quell doubts introduced by the short report. The company's stock jumped 15% as of market close.

Motley Fool 6 days ago

TEM
+5.81%

^GSPC
Tempus AI recovers 15% as Wall Street downplays Spruce Point allegations

Investing.com -- Shares of Tempus AI Inc (NASDAQ:TEM) surged 15% on Monday, recovering some of last week’s sharp losses after a short-seller report from Spruce Point Capital triggered a 13% weekly drop. The rebound followed a note from TD Cowen’s Dan Brennan, which downplayed the severity of the concerns raised and characterized the selloff as largely overdone.

Investing.com 6 days ago

TEM
+5.81%
Tempus AI rebound, Meta's AI ad push, Broadcom earnings optimism

Market Domination co-host Julie Hyman tracks today's top moving stocks and biggest market stories in this Market Minute. Tempus AI (TEM) shares jump after TD Cowen responded to a recent short report, calling some of its claims exaggerated. Advertising stocks fall as Meta (META) reportedly plans to fully automate ad creation and targeting with artificial intelligence (AI) by the end of next year, according to The Wall Street Journal. Meanwhile, Broadcom (AVGO) shares rise ahead of its June 5 earnings report. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

Yahoo Finance Video 6 days ago

TEM
+5.81%

AVGO

META
Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers

CHICAGO, June 02, 2025--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced xM for treatment response monitoring (TRM), a liquid biopsy assay intended to detect molecular response to immune-checkpoint inhibitor (ICI) therapy in advanced solid tumors. xM for TRM is the newest addition to Tempus’ growing portfolio of sensitive assays for monitoring molecular response and minimal residual disease (MRD). It is

Business Wire 6 days ago

TEM
+5.81%
Cathie Wood buys $13.9 million of popular AI stock

Here are Cathie Wood’s latest buys.

TheStreet 7 days ago

TEM
+5.81%

^GSPC
Introducing Tempus One in the EHR with Integrated Guidelines

CHICAGO, June 01, 2025--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the expansion of Tempus One—its generative AI clinical assistant—with direct integration into electronic health record (EHR) systems. By integrating AI at every point of the clinical care process, the expanded capabilities of Tempus One offer physicians in oncology and beyond more support in treatment decisions. Tempus One is uniqu

Business Wire 7 days ago

TEM
+5.81%
Tempus AI hits back at scathing short report

The health care AI startup has responded to some scathing accusations.

TheStreet 8 days ago

TEM
+5.81%
Tempus AI announces 10 abstracts accepted for presentation at 2025 ASCO meeting

Tempus AI (TEM) announced that ten abstracts have been accepted for presentation at the 2025 American Society of Clinical Oncology, ASCO, Annual Meeting. The event will take place May 30 – June 3 in Chicago, Illinois. Tempus will present its cutting-edge clinical findings and innovative technologies, highlighting the company’s use of AI-driven solutions to advance precision oncology. “At ASCO 2025, we are proud to showcase a diverse portfolio of studies that highlight how our cutting-edge techno

TipRanks 8 days ago

TEM
+5.81%
Tempus Introduces Fuses, A Program Designed to Transform Therapeutic Research and Build the Largest Diagnostic Platform Using its Novel Foundation Model

CHICAGO, May 31, 2025--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the launch of its Fuses program. This initiative will harness Tempus’ proprietary dataset to generate valuable insights for both patient care and research, combining the power of its data and machine learning capabilities to develop an AI enabled-diagnostic platform offering physicians the largest suite of algorithmic tests designed

Business Wire 8 days ago

TEM
+5.81%
Why Tempus AI Stock Plummeted This Week

Tempus AI is a healthcare-oriented artificial intelligence company. Spruce Point Capital Management released a report critical of Tempus AI this week. Investors should exercise caution with Tempus AI stock but not be deterred from considering an investment solely based on the critical report.

Motley Fool 9 days ago

TEM
+5.81%
Tempus Announces 10 Abstracts Accepted for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting

CHICAGO, May 30, 2025--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that ten abstracts have been accepted for presentation at the 2025 American Society of Clinical Oncology (ASCO®) Annual Meeting. The event will take place May 30 - June 3 in Chicago, Illinois. Tempus will present its cutting-edge clinical findings and innovative technologies, highlighting the company’s use of AI-driven solutions to

Business Wire 9 days ago

TEM
+5.81%
Why Tempus AI, Inc. (TEM) Went Down On Wednesday

We recently published a list of 10 Stocks Crash Harder Than Wall Street. In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against other worst-performing stocks. Tempus AI nosedived by 19.23 percent on Wednesday to close at $53.20 apiece following a short-seller report’s negative comments and concerns about […]

Insider Monkey 10 days ago

TEM
+5.81%
Tempus AI, Box earnings, Victoria's Secret: Trending Tickers

Tempus AI (TEM) stock is tanking following a short seller report that raised concerns about the company, its products, and its financials. Tempus AI told Yahoo Finance in a statement that the report is "riddled with hypotheticals and inaccuracies." Box (BOX) stock surges on its first quarter earnings beat and increased full-year revenue forecast. Victoria's Secret (VSCO) stock is sinking as the retailer's website is down. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

Yahoo Finance Video 11 days ago

BOX

BXNCP

TEM
+5.81%

Performance Overview

Return	TEM	S&P 500 (^GSPC)
YTD	+83.86%	+2.02%
1-Year	+55.18%	+12.09%
3-Year	+55.18%	+45.59%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Tempus AI, Inc. (TEM)

Why Shares of Tempus AI Are Jumping Higher This Week

Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape?

Zacks Investment Ideas feature highlights: Tempus AI, SoundHound AI and Innodata

3 AI Stocks Flying Under the Radar

Zacks Investment Ideas feature highlights: Nvidia, Alphabet, Constellation Energy and Meta Platform

Beyond LLMs: How Propense.ai & Tempus AI are Shaking up Legacy Industries

Why Tempus AI, Inc. (TEM) Skyrocketed On Monday

Why Tempus AI Stock Soared 15% Today

Tempus AI recovers 15% as Wall Street downplays Spruce Point allegations

Tempus AI rebound, Meta's AI ad push, Broadcom earnings optimism

Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers

Cathie Wood buys $13.9 million of popular AI stock

Introducing Tempus One in the EHR with Integrated Guidelines

Tempus AI hits back at scathing short report

Tempus AI announces 10 abstracts accepted for presentation at 2025 ASCO meeting

Tempus Introduces Fuses, A Program Designed to Transform Therapeutic Research and Build the Largest Diagnostic Platform Using its Novel Foundation Model

Why Tempus AI Stock Plummeted This Week

Tempus Announces 10 Abstracts Accepted for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting

Why Tempus AI, Inc. (TEM) Went Down On Wednesday

Tempus AI, Box earnings, Victoria's Secret: Trending Tickers

Performance Overview